Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash

di Hichert, Vivien, Scholl, Catharina, Steffens, Michael, Paul, Tanusree, Schumann, Christian, Rüdiger, Stefan, Boeck, Stefan, Heinemann, Volker, Kächele, Volker, Seufferlein, Thomas, Stingl, Julia
Pubblicato in Oncotarget (2017)

Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity

di Kemski, Sarah, Molitor, Vivien, Steffens, Michael, Nümm, Tim J., Herrmann, Nadine, Hornung, Thorsten, Bieber, Thomas, Schumann, Christian, Kächele, Volker, Seufferlein, Thomas, Heinemann, Volker, Scholl, Catharina, Stingl, Julia Carolin
Pubblicato in Oncotarget (2021)

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

di Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Pubblicato in BMC Cancer (2016)